| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in GRAL over the last quarter tilts toward selling: insiders offloaded a net 129,944 shares worth roughly $14.8M. In the past 30 days, 0 insiders bought and 3 sold.
On the other side, 3 insiders reduced their position over the period. GRAL sits in the Life Sciences Tools & Services industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 518.6K | $25.89M | - | |
| CEO | 357.5K | $48.42M | -81,452 | |
| CFO | 225.4K | $32.99M | -27,719 | |
| Other | 155.9K | $22.82M | -7,873 | |
| Dir | 45.9K | $6.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Ofman Joshua J. | Chief Executive Officer | Sell | 20,000 | $136.85 | $2,736,944.71 | -5.5% | - | - | |
| Oct 5, 2026 | Freidin Aaron | Chief Financial Officer | Sell | 23,619 | $146.39 | $3,457,585.41 | -9.5% | - | - | |
| Oct 5, 2026 | Partridge Andrew John | Chief Growth Officer | Sell | 7,873 | $146.39 | $1,152,528.47 | -4.8% | - | - | |
| Sep 21, 2026 | Ofman Joshua J. | Chief Executive Officer | Sale+OE | 61,452 | $97.74 | $6,006,378.37 | -14.5% | - | - | |
| Sep 21, 2026 | Freidin Aaron | Chief Financial Officer | Sell | 4,100 | $93.34 | $382,679.13 | -1.6% | - | - | |
| Aug 27, 2026 | Ofman Joshua J. | Chief Executive Officer | Sell | 5,000 | $85.02 | $425,098.00 | -1.2% | - | - | |
| Aug 27, 2026 | Freidin Aaron | Chief Financial Officer | Sell | 7,900 | $85.01 | $671,579.00 | -3.0% | - | - | |
| Jun 4, 2026 | Partridge Andrew John | Chief Growth Officer | Sell | 1,491 | $61.08 | $91,070.28 | -0.9% | - | - | |
| Apr 8, 2026 | Ofman Joshua J. | President | Sell | 61,665 | $49.92 | $3,078,168.80 | -14.2% | +35.5% | - | |
| Apr 8, 2026 | Freidin Aaron | Chief Financial Officer | Sell | 45,806 | $49.92 | $2,286,525.59 | -14.9% | +35.5% | - |